It is important to know the drug’s chances for success before setting a royalty rate. "The analysis calculates the present value of the money saved by owning a patent and not having to pay ...

CEO Paddy Nicol's leadership has transformed Orogen into a successful royalty company, offering a low-risk, high-upside investment in the gold sector. Orogen Royalties also has dozens of other ...